Home / Brands / Golden State Medical Supply
Golden State Medical Supply Recalls
53 recalls on record · June 11, 2014 to June 17, 2026 · Drugs
Recalls by year
14
15
16
18
19
20
21
22
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 17, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium, 100 mg tablets, 90 count bottle, NDC 60429-318-90
Hazard: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
July 17, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10
Hazard: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
July 17, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
Hazard: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
July 17, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium, 50 mg tablets, 30 count bottle, NDC 60429-317-30
Hazard: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
May 29, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 100 mg 1000 count bottle NDC 60429-318-10 Rx only GSMS Incorporated
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
May 29, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 100 mg 90 count bottle NDC 60429-318-90 Rx only GSMS Incorporated
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
May 29, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx only GSMS Incorporated
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
May 29, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 25 mg 90 count bottle NDC 60429-316-90 Rx only GSMS Incorporated
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
May 29, 2019DrugsFDA
Golden State Medical Supply Inc. recalls Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only GSMS Incorporated
Hazard: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
November 28, 2018DrugsFDA
Golden State Medical Supply Inc. recalls IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90) Rx Only, M
Hazard: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
November 28, 2018DrugsFDA
Golden State Medical Supply Inc. recalls IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90) Rx Only, M
Hazard: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
November 28, 2018DrugsFDA
Golden State Medical Supply Inc. recalls IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 1178
Hazard: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
August 24, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
Hazard: Failed Dissolution Specifications: Out-of-specification results in retained sample.
August 24, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b) 90 capsul
Hazard: Failed Dissolution Specifications: Out-of-specification results in retained sample.
July 20, 2016DrugsFDA
Golden State Medical Supply Inc. recalls DULOXETINE Delayed-Release Capsules, USP, 60 mg, 1000 count bottles, Rx only, Manufactured by: Laboratorios del Dr. Este
Hazard: Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018
March 16, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Atorvastatin Calcium 80 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc. Toronto, Onta
Hazard: Failed Impurities/Degradation Specifications
March 16, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Atorvastatin Calcium 40 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc. Toronto, Onta
Hazard: Failed Impurities/Degradation Specifications
March 16, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Atorvastatin Calcium 20 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc. Toronto, Onta
Hazard: Failed Impurities/Degradation Specifications
March 16, 2016DrugsFDA
Golden State Medical Supply Inc. recalls Atorvastatin Calcium 10 mg, 10 tablets per blister,100-count package, Rx Only Manufactured by Apotex Inc. Toronto, Onta
Hazard: Failed Impurities/Degradation Specifications
December 16, 2015DrugsFDA
Golden State Medical Supply Inc. recalls MECLIZINE HYDROCHLORIDE TABLETS, 25 mg, Packaged in a) 100 ct Bottles (NDC: 60429-205-01) and b) 1000 ct Bottles (NDC: 6
Hazard: Failed Impurities/Degradation Specifications: Out of specification for impurities.
December 16, 2015DrugsFDA
Golden State Medical Supply Inc. recalls MECLIZINE HYDROCHLORIDE TABLETS, 12.5 mg, Packaged in 1000 ct Bottles, Rx Only. Manufactured by: Par Pharmaceuticals Co
Hazard: Failed Impurities/Degradation Specifications: Out of specification for impurities.
September 16, 2015DrugsFDA
Golden State Medical Supply Inc. recalls METHOCARBAMOL TABLETS, USP 500 mg, 500 Count Bottles, Rx Only. Manufactured by AustarPharma LLC, Edison, NJ 08837, USA,
Hazard: Presence of Foreign Substance: Presence of hair.
June 11, 2014DrugsFDA
Golden State Medical Supply Inc. recalls LOSARTAN POTASSIUM Tablets, USP, 50 mg, 30 count bottles, Rx only, Manufactured by Arrow Pharm (Malta) Ltd., Bizebbugia,
Hazard: Presence of Foreign Substance; some bottles may contain debris that was swept up during cleaning